Next Article in Journal
BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy
Previous Article in Journal
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(22), 5617; https://doi.org/10.3390/cancers14225617
Action Date Notes Link
article xml file uploaded 16 November 2022 07:18 CET Original file -
article xml uploaded. 16 November 2022 07:18 CET Update https://www.mdpi.com/2072-6694/14/22/5617/xml
article pdf uploaded. 16 November 2022 07:18 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5617/pdf
article supplementary file uploaded. 16 November 2022 07:18 CET - https://www.mdpi.com/2072-6694/14/22/5617#supplementary
article html file updated 16 November 2022 07:20 CET Original file -
article html file updated 3 March 2023 20:20 CET Update https://www.mdpi.com/2072-6694/14/22/5617/html
Back to TopTop